Guardian Capital LP Innoviva, Inc. Transaction History

Guardian Capital LP

  • $2.47 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$13.96 - $18.26 $164,937 - $215,741
-11,815 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$13.63 - $15.7 $17,350 - $19,986
1,273 Added 12.08%
11,815 $180,000
Q1 2018

May 15, 2018
BUY
$13.8 - $16.99 $145,479 - $179,108
10,542 New
10,542 $175,000

Others Institutions Holding INVA

# of Institutions
228
Shares Held
79.1M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Guardian Capital LP Portfolio

Follow Guardian Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email